Navigation Links
The Leukemia & Lymphoma Society: Impacting Blood Cancers and Beyond
Date:2/19/2013

tologic malignancies with a unique link to the cancer research community. Many innovations such as multi-drug chemotherapy and stem cell transplantation started as blood cancer therapies. In fact, nearly 50 percent of all cancer drugs newly approved by the US Food & Drug Administration (FDA) in the last 12 years were first approved for blood cancers. "Blood cancer research is a gateway to treatments and even cures for many other cancers, as well as some inflammatory diseases, such as rheumatoid arthritis (RA)," explains DeGennaro. "LLS and our partners are pioneering cutting-edge cancer research at the cellular and molecular level, which has the capacity to offer significant contributions beyond even blood cancers."

"Someday is Today"

"We felt it was time to put a stake in the ground, and to shine the spotlight on the urgency and accomplishments we have made toward finding cures for blood cancers. 'Someday is Today' is our platform to rally support for this cause," explains John Walter , LLS chief executive officer. "People talk about curing cancer at some point in the future.  But, for LLS, someday is today. Contributions made to this organization – through partners, volunteers and generous donors – are driving cures right now. The reality is, if you want to reduce the incidence of lung cancer, stop smoking.  If you want to reduce the incidence of melanoma, use sun block. If you want to prevent the incidence of blood cancer, invest in a cure."

The "Someday is Today" initiative will launch this month nationwide, with emphasis in New York, Chicago, Los Angeles, San Francisco, Washington DC, and Dallas. The platform was developed by LLS in conjunction with branding agency Interplanetary, and is being supported by TV and radio
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Data Presented at American Society of Hematology from Ibrutinib Phase 1b/2 and Phase 2 Trials Suggest High and Durable Response in Chronic Lymphocytic Leukemia
2. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
3. Inovio Pharmaceuticals Announces Positive Interim Results in Phase II Leukemia Trial
4. Global Acute Myeloid Leukemia (AML) Therapeutics Industry
5. The Leukemia & Lymphoma Society Awards $12 Million in Research Grants in Four Critical Areas of Unmet Medical Need
6. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
7. Study of Cell Therapeutics Tosedostat for Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Now Enrolling
8. Acute Lymphocytic Leukemia: Impressive Results With the Monoclonal Antibody Blinatumomab in Patients With Refractory Disease
9. How Malignant Cells in Patients With Chronic Lymphocytic Leukemia Escape T Cell Recognition and Attack
10. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
11. Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 28, 2015 First Harvest Financial ... leading source for advice to legal medical cannabis companies. ... and strategic planning to start-ups and entrepreneurs, First Harvest ... industry. , Wall Street veteran, Kevin Gillespie, has ... President and Portfolio Manager. Due to early success ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Spartan Bioscience ... founder, has been selected by the Ottawa Chamber of ... 40. Dr. Lem was selected from over 240 applicants ... involvement. , Prior to Spartan, Dr. Lem founded Plexagen ... DNA Genotek. He holds a Medical Degree from the ...
(Date:4/28/2015)... 2015 The Alliance for Clinical ... non-profit organization dedicated to transforming the medical products ... system for clinical research, announced today that it ... type of clinical research event in Boston, October ... is changing,” said Greg Koski, PhD, MD, Co-founder ...
(Date:4/27/2015)... VANCOUVER , April 27, 2015 /PRNewswire/ - iCo ... ICOTF), today reported financial results for the year ... are expressed in Canadian dollars and presented under ... year,s phase two DME results did not provide ... but extremely undervalued assets remain at iCo Therapeutics", ...
Breaking Biology Technology:Leading Medical Cannabis Advisor, First Harvest Financial, Welcomes Top Executives Aboard 2Leading Medical Cannabis Advisor, First Harvest Financial, Welcomes Top Executives Aboard 3Spartan Bioscience Announces Paul Lem Named Ottawa’s Top 40 Under 40 2ACRES Announces Innovative Clinical Research Event--SYNERGY 2ACRES Announces Innovative Clinical Research Event--SYNERGY 3ACRES Announces Innovative Clinical Research Event--SYNERGY 4iCo Therapeutics Announces Year End 2014 Financial Results 2iCo Therapeutics Announces Year End 2014 Financial Results 3iCo Therapeutics Announces Year End 2014 Financial Results 4
... Ventures, a venture capital,firm specializing in life science ... firm as its fourth partner. Broderick brings more,than ... fund,management, and technology commercialization. Before coming to ... in Milwaukee, WI, where he served on its ...
... EDT, EDMONTON, BELLEVUE, WASHINGTON, Sept. 12 /PRNewswire-FirstCall/ ... (the "Company") today announced that,the Company,s Board of ... of incorporation from the federal jurisdiction of Canada ... of America through a plan of,arrangement. Under the ...
... Inc., a,biotechnology company translating the complexity of human ... its president and,CEO, Dr. Keith O. Elliston, has ... Summit in Arlington, Va., September 17-18. Dr. ... on,"Enhancing Development and Commercial Value Added in Care ...
Cached Biology Technology:Dan Broderick Joins Prolog Ventures as Partner 2Dan Broderick Joins Prolog Ventures as Partner 3Biomira Announces Plan to Reincorporate in the United States 2Biomira Announces Plan to Reincorporate in the United States 3Biomira Announces Plan to Reincorporate in the United States 4Biomira Announces Plan to Reincorporate in the United States 5Biomira Announces Plan to Reincorporate in the United States 6Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit 2
(Date:3/24/2015)...   NexID Biometrics LLC, whose spoof-mitigation technology ... announced the beginning of shipments of version 2.0 of ... company, based in Potsdam, N.Y. , ... which began here today at the Walter E. Washington ... its SDK boosts the accuracy rate range to 96.5 ...
(Date:3/23/2015)...  In the 2014 fiscal year, irs.gov recorded over ... figure accounts for a fraction of the estimated losses ... exceeds $11 billion globally. The polygraph has traditionally been ... occurred. Investor Mark Saint Juste along with ... partnered to administer the test in a new ...
(Date:3/20/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces its biometric payment technology, ... featured in 2015 "I Want That" International CES Special, ... the DIY Network.   DIY,s "I Want ... site of the 2015 International CES for a firsthand ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... taken part in an international study which has discovered a ... of a region. And the secret lies in crushed ... been spent by researchers gathering, classifying and recording insects and ... region. Any changes to the biodiversity of that area could ...
... "Magic" mushrooms are well known for their hallucinogenic properties. ... development and how they should be classified in the ... evolutionary past of a fascinating fungi that has wide ... variety of medicinal applications. In the 19th ...
... Sciences Leopoldina and the Academy of Science of South Africa ... to a cooperation agreement signed in Pretoria by Leopoldina President ... of South Africa, Professor Daya Reddy. The Leopoldina ... Science of South Africa for many years, and the 2012/2013 ...
Cached Biology News:Insect 'soup' serving up rapid biodiversity monitoring 2Family matters: Evolutionary relationships among species of 'magic' mushrooms shed light on fungi 2Leopoldina signs cooperation agreement with the Academy of Science of South Africa 2
... Trap Time of Flight Mass Analyzer for superior sensitivity, mass accuracy, ... - 25,000 m/z, * Precursor ion selection range: 150 - 4000 ... 5 ppm with internal reference, * Dynamic range: 4 orders of ... ...
Four siRNAs targeting your gene of interest, providing gene silencing with 100% satisfaction guaranteed High knockdown potency , High specificity for minimal off-target effects , Flexible siR...
Mouse polyclonal antibody to BTAF1 - BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae)...
... series combines Harvard Apparatuss best pump mechanism, a ... range of configuration options. A lookup table in ... from all the major manufacturers. A bright, two ... information from across the lab. All models have ...
Biology Products: